PH Medical Surgery
ActiveSummary
PH Medical Surgery has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €54k and a net result of €47k. Equity is growing by ~12.7% per year across the filed fiscal years. Its solvency ranks better than 31% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
80
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+24
Solvency63▲+5
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity tight (current ratio 1.42 against 1.42 in 2024; short-term debt: 39.2% and cash: 17.2% of total assets), and 61.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
38.3%
Return on assets
32.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
26 d late
2024
27 d early
2023
14 d late
2022
32 d late
2021
33 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€54k▲ 45.6%
2024 · €37k
2021: €29k
2022: €52k
2023: €77k
2024: €37k
2021 → 2025
Total assets
€142k▲ 24.5%
2024 · €114k
2021: €37k
2022: €74k
2023: €107k
2024: €114k
2021 → 2025
Net result
€47k▲ 570%
2024 · €7k
2021: €26k
2022: €23k
2023: €26k
2024: €7k
2021 → 2025
Working capital
€24k▼ 26.3%
2024 · €32k
2021: €29k
2022: €50k
2023: €72k
2024: €32k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€29k-€52k▲ 77.8%€77k▲ 49.8%€37k▼ 51.8%€54k▲ 45.6%
Operating result€34k-€29k▼ 12.1%€33k▲ 12.2%€6k▼ 81.6%€61k▲ 902%
Net result€26k-€23k▼ 13.3%€26k▲ 13.9%€7k▼ 73.0%€47k▲ 570%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 902% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €142k
Fixed assets
€63k ▲ 1,070%
Current assets
€79k ▼ 27.1%
Equity and liabilities €142k
Equity
€54k ▲ 45.6%
Debt
€88k ▲ 14.2%
Debt's share of the balance-sheet total falls from 67.3% to 61.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€65k▲
2024 · €7k
Cash flow
€50k▲
2024 · €8k
Current ratio
1.42▲
2024 · 1.42
Debt to equity
1.61▼
2024 · 2.06
ROE
85.6%▲
2024 · 18.6%
ROA
32.8%▲
2024 · 6.1%
Interest coverage
134.73▲
2024 · 13.74
Debt ≤ 1 year
€56k▼
2024 · €77k
Debt > 1 year
€32k
Income taxes
€18k▲
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€114k€142k▲
Fixed assets21/28€5k€63k▲
Tangible fixed assets22/27€3k€61k▲
Plant, machinery and equipment23€1k€672▼
Furniture and vehicles24€2k€60k▲
Financial fixed assets28€2k€2k=
Current assets29/58€109k€79k▼
Amounts receivable within one year40/41€13k€3k▼
Trade receivables40€3k€3k▼
Other amounts receivable41€10k-
Current investments50/53€69k€50k▼
Cash at bank and in hand54/58€23k€24k▲
Deferred charges and accrued income490/1€4k€2k▼
Equity and liabilities
Total equity and liabilities10/49€114k€142k▲
Equity10/15€37k€54k▲
Contributions10/11€3k€3k=
Profit (loss) carried forward14€34k€51k▲
Amounts payable17/49€77k€88k▲
Amounts payable after more than one year17-€32k
Financial debts170/4-€32k
Amounts payable within one year42/48€77k€56k▼
Current portion of amounts payable after more than one year42-€8k
Trade debts44€2k-
Suppliers440/4€2k-
Taxes, remuneration and social security45€14k€14k▼
Taxes450/3€14k€14k▼
Other amounts payable47/48€60k€34k▼
Accrued charges and deferred income492/3€88-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€4k▲
Other operating charges640/8€710€557▼
Gross operating margin9900€8k€65k▲
Operating profit (loss)9901€6k€61k▲
Financial income75/76B€5k€4k▼
Recurring financial income75€5k€4k▼
Financial charges65/66B€531€481▼
Recurring financial charges65€531€481▼
Profit (loss) for the period before taxes9903€11k€65k▲
Income taxes67/77€4k€18k▲
Profit (loss) for the period9904€7k€47k▲
Profit (loss) for the period to be appropriated9905€7k€47k▲
Appropriation of the result
Profit (loss) to be appropriated9906€81k€81k▼
Profit (loss) brought forward from the previous period14P€74k€34k▼
Profit to be distributed694/7€47k€30k▼
Return on contributions (dividend)694€47k€30k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 26 days late
2025
31-12
Financial
Highest result since 2021net €47k ▲570%
Operating result €61k, net result €47k, both a record.
04-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €7k ▼73%
Net result drops to €7k, the lowest in the series; recovery starts the following year.
14-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 14 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
02-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 33 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beersel · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Steenrotsstraat 51652 BeerselGround area
1,376 m²
Building footprint
178 m²
Volume, LiDAR
1,019 m³
2 parcels, Brussels, Flanders · tallest building 8.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PH Medical Surgery
since 20212.314.870.257
2 parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23001D0023/00S004 | Flanders | 1,284 m² | 1 · 178 m² | 8.9 m · 2 fl. |
| 21808H0030/00T000 | Brussels | 92 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MEDISCH KABINET DSC
BE 0772.923.021
Schilde · Eq €54,326
OGER OPHTALMOLOGIE
BE 0823.621.852
Braine-l'Alleud · Eq €54,386
RTMU
BE 1027.079.847
Sint-Martens-Latem · Eq €54,423
Centre deMédecine Spécialisée du Mutsaert, Polyclinique
BE 0403.025.003
Grimbergen · Eq €54,456
DOCTEUR ANTOINE MOREAU
BE 0740.817.407
Sprimont · Eq €54,514
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 5,200 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-03-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
84239Public administration and defence; compulsory social security
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.